Vimarsana
Biggest News Aggregation in the World

Page 5 - Updated Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Updated Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Updated Phase Today - Breaking & Trending Today

Innovent and IASO Bio Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022 - Vimarsana News

Innovent and IASO Bio Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022

Published: June 13, 2022

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

Source: prnewswire.com
Related Topics:
United StatesHong KongInnovent BiologicsEquecabtagene Autoleucel ChiAdimab IncyteEquecabtagene AutoleucelChunrui LiEli LillyEquecabtagene Autoleucel InnoventEuropean Hematology AssociationMd Anderson Cancer CenterChina National Medical Products AdministrationHuazhong University Of Science TechnologyDepartment Of HematologyInnovent Or CompanyIncyte CorporationHuazhong University Of SciencePrnewswire Innovent Biologics IncDrug AdministrationTongji Medical CollegeTongji Hospital Of Medical CollegeOffice Of Orphan Products DevelopmentInnovent Biologics IncAnnual MeetingUpdated Phase
Innovent and IASO Bio Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022 | DNA RNA and Cells - Vimarsana News

Innovent and IASO Bio Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022 | DNA RNA and Cells

Published: June 13, 2022

Innovent and IASO Bio Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022

Source: pipelinereview.com
Related Topics:
United StatesHong KongEquecabtagene Autoleucel ChiAdimab IncyteEquecabtagene AutoleucelChunrui LiEli LillyEquecabtagene Autoleucel InnoventHuazhong University Of ScienceEuropean Hematology AssociationDrug AdministrationMd Anderson Cancer CenterI Innovent Biologics IncHuazhong University Of Science TechnologyTongji Medical CollegeDepartment Of HematologyOffice Of Orphan Products DevelopmentTongji Hospital Of Medical CollegePresent Updated DataChinai JuneInnovent BiologicsAnnual MeetingUpdated PhaseRefractory MultipleTongji Hospital
Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bispecific Antibody Talquetamab in Heavily Pretreated Patients with Multiple Myeloma - Vimarsana News

Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bispecific Antibody Talquetamab in Heavily Pretreated Patients with Multiple Myeloma

Published: June 10, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced updated results from the Phase 1 MonumenTAL-1 first-in-human...

Source: prnewswire.com
Related Topics:
United StatesObrian KenneyMonique MinnemaSen ZhuangSatu GlaweJanssen Biotech IncAmerican Society Of Clinical OncologyEuropean Hematology AssociationJanssen Research DevelopmentJanssen Pharmaceutical CompaniesJanssen Pharmaceutical Companies Of JohnsonClinical ResearchDepartment Of HematologyAmerican Cancer SocietyNone Of The Janssen Pharmaceutical CompaniesOther Administration ReactionsUniversity Medical CenterExchange CommissionCompanies Of JohnsonAmgen IncHematology AssociationAnnual CongressClinical OncologyAnnual MeetingConfidence Interval
Janssen Presents Updated Data at EHA for Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma - Vimarsana News

Janssen Presents Updated Data at EHA for Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma

Published: June 10, 2022

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced updated efficacy and safety results from the teclistamab cohort of the...

Source: prnewswire.com
Related Topics:
United StatesYusri ElsayedBernadette KingPaula RodrSatu GlaweJanssen Biotech IncEuropean Hematology AssociationCancer Research InstituteJanssen Research DevelopmentJanssen Pharmaceutical CompaniesJanssen Pharmaceutical Companies Of JohnsonDepartment Of HematologyAmerican Cancer SocietyNone Of The Janssen Pharmaceutical CompaniesOther Administration ReactionsDrug AdministrationEuropean CommissionExchange CommissionCompanies Of JohnsonAmgen IncEuropean Medicines AgencyHematology AssociationAnnual CongressUniversidad De NavarraVice President
Investegate |Syncona Limited Announcements | Syncona Limited: Autolus Reports Q1 2022 Financial Results - Vimarsana News

Investegate |Syncona Limited Announcements | Syncona Limited: Autolus Reports Q1 2022 Financial Results

Published: May 5, 2022

Investegate announcements from Syncona Limited, Autolus Reports Q1 2022 Financial Results

Source: investegate.co.uk
Related Topics:
United StatesUnited KingdomCity OfOlivia ManserAndrewj OakleySusana NoonanJulia WilsonLucinda CrabtreeCollins Fergus WittExchange Commission OnEuropean Hematology AssociationAmerican Society Of Gene Cell TherapyDrug AdministrationSa Noonan CommunicationsExchange CommissionUs Food Drug AdministrationAutolus Therapeutics PlcEuropean Medicines AgencySyncona LtdSyncona LimitedMinimal Residual DiseaseJulia BradshawTherapeutics Reports First QuarterB Cell Acute Lymphoblastic LeukemiaChristian Itin